Draxis revenue jumps 59%

Article Abstract:

Draxis Health Inc., a Toronto, Ontario-based company, has reported it lost a total of C$1.3 million, or 4 cents a share, for the quarter that ended Sept. 30, 1998, an improvement of 59% compared to the $2.9 million, or 10 cents per share, it lost in 1997 for the same quarter. The company attributed much of the losses to the costs of launching SpectroDerm, a dermatology product, in the US. Revenues at Draxis Health during the third quarter also improved to C$9.8 million from C$6.2 million a year earlier.

Comment:

Reports it lost a total of C$1.3 million, or 4 cents a share, for the quarter that ended 9/30/98

Pharmaceutical Preparation Manufacturing, Ontario, Dermatological Preparations, Dermatologic agents, Article, Draxis Health Inc.

---

Canadian Medical results shatter estimates

Article Abstract:

Canadian Medical Laboratories Ltd of Mississauga, Ontario, has posted a profit of C$15.5 million, or 80 cents a share, on revenue of C$89.4 million in the first nine months if 1999. The company had C$8.6 million, or 52 cents a share, on C$57 million in the year-ago period. The company attributed that improved earnings to its acquisition of the assets of bankrupt MedChem Health Care Ltd of Toronto and improved results for its durg research business.

Canada, Testing Laboratories, Canadian Medical Laboratories Ltd.

---

Similar abstracts:

• Abstracts: Trust expects profit on Calgary office development. TLC goes for a ride as it denies raft of reports. RealFund shifts strategy away from acquisitions
• Abstracts: Term-to-100 insurance rates rising. Investors Group fund jumps into cash
• Abstracts: Caisse unit to double venture investments. Canada's automotive advantage shrinking: Zetsche: Closing quality gap, Chrysler chief says

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.